Sort by

Send to

Choose Destination

Search results

Items: 12


Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Balestre E, Eholié SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiébaut R; International epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

AIDS. 2012 May 15;26(8):951-7. doi: 10.1097/QAD.0b013e3283528ad4.


Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.

Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M; Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA.

J Int AIDS Soc. 2012 Jan 30;15(1):5. doi: 10.1186/1758-2652-15-5.


Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire.

Jaquet A, Djima MM, Coffie P, Kacou HD, Eholie SP, Messou E, Minga A, Guehi C, Yavo JC, Bissagnene E, Dabis F, Ekouevi DK; IeDEA West Africa Collaboration.

Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1303-10. doi: 10.1002/pds.2182. Epub 2011 Jul 7.


Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, Minga A, Messou E, Sow PS, Lewden C, Traoré HA, Bissagnene E, Dabis F; IeDEA West Africa Collaboration.

Trop Med Int Health. 2010 Jun;15 Suppl 1:34-42. doi: 10.1111/j.1365-3156.2010.02505.x.


Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.

Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Touré S, Seyler C, Fassinou P, Dabis F, N'Dri-Yoman T, Anglaret X, Leroy V.

Bull World Health Organ. 2010 Jul 1;88(7):490-9. doi: 10.2471/BLT.09.068015. Epub 2009 Dec 21.


First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Drylewicz J, Eholie S, Maiga M, Zannou DM, Sow PS, Ekouevi DK, Peterson K, Bissagnene E, Dabis F, Thiébaut R; International epidemiologic Databases to Evaluate AIDS (IeDEA) West Africa Collaboration.

AIDS. 2010 Apr 24;24(7):1043-50.


[Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa].

Bashi J, Balestre E, Messou E, Maiga M, Coffie PA, Zannou DM, Ba-Gomis O, Traore HA, Eholie S, Minga A, Sow PS, Bissagnene E, Dabis F, Ekouevi DK; Collaboration IeDEA West Africa.

Med Mal Infect. 2010 Aug;40(8):449-55. doi: 10.1016/j.medmal.2009.11.003. Epub 2009 Dec 31. French.


Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.

Walenda C, Kouakoussui A, Rouet F, Wemin L, Anaky MF, Msellati P.

J Trop Pediatr. 2009 Jun;55(3):170-6. doi: 10.1093/tropej/fmn106. Epub 2008 Dec 9.


CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire.

De Beaudrap P, Rouet F, Fassinou P, Kouakoussui A, Mercier S, Ecochard R, Msellati P.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):70-6. doi: 10.1097/QAI.0b013e3181831847.


Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.

Rouet F, Fassinou P, Inwoley A, Anaky MF, Kouakoussui A, Rouzioux C, Blanche S, Msellati P; ANRS 1244/1278 Programme Enfants Yopougon.

AIDS. 2006 Nov 28;20(18):2315-9.


Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast.

Kouakoussui A, Fassinou P, Anaky MF, Elenga N, Laguide R, Wemin ML, Toure R, Menan H, Rouet F, Msellati P.

Paediatr Respir Rev. 2004 Dec;5(4):311-5.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk